SARS-CoV-2 Infection in patients with cystic fibrosis. An overwiew

The novel coronavirus SARS-CoV-2 was first identified in China in December 2019 and has since spread worldwide. People with Cystic Fibrosis (CF) have reduced survival mainly because of respiratory failure due to chronic pulmonary infections. Therefore, CF patients should be considered to have an inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Fainardi, Valentina, Longo, Francesco, Chetta, Alfredo, Esposito, Susanna, Pisi, Giovanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2020
Materias:
Reviews / Focus on
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716958/
https://www.ncbi.nlm.nih.gov/pubmed/32921729
http://dx.doi.org/10.23750/abm.v91i3.10391
_version_ 1783619262108139520
author Fainardi, Valentina
Longo, Francesco
Chetta, Alfredo
Esposito, Susanna
Pisi, Giovanna
author_facet Fainardi, Valentina
Longo, Francesco
Chetta, Alfredo
Esposito, Susanna
Pisi, Giovanna
author_sort Fainardi, Valentina
collection PubMed
description The novel coronavirus SARS-CoV-2 was first identified in China in December 2019 and has since spread worldwide. People with Cystic Fibrosis (CF) have reduced survival mainly because of respiratory failure due to chronic pulmonary infections. Therefore, CF patients should be considered to have an increased risk of developing severe manifestations in case of SARS-CoV-2 infection. Surprisingly, the results of recent studies concerning SARS-CoV-2 infection in patients with CF show that in these patients the infection rate was lower than that of the general population. Various factors have been considered to explain a possible protective effect of CF against SARS-CoV-2 infection.
format Online
Article
Text
id pubmed-7716958
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-77169582020-12-07 SARS-CoV-2 Infection in patients with cystic fibrosis. An overwiew Fainardi, Valentina Longo, Francesco Chetta, Alfredo Esposito, Susanna Pisi, Giovanna Acta Biomed Reviews / Focus on The novel coronavirus SARS-CoV-2 was first identified in China in December 2019 and has since spread worldwide. People with Cystic Fibrosis (CF) have reduced survival mainly because of respiratory failure due to chronic pulmonary infections. Therefore, CF patients should be considered to have an increased risk of developing severe manifestations in case of SARS-CoV-2 infection. Surprisingly, the results of recent studies concerning SARS-CoV-2 infection in patients with CF show that in these patients the infection rate was lower than that of the general population. Various factors have been considered to explain a possible protective effect of CF against SARS-CoV-2 infection. Mattioli 1885 2020 2020-09-07 /pmc/articles/PMC7716958/ /pubmed/32921729 http://dx.doi.org/10.23750/abm.v91i3.10391 Text en Copyright: © 2020 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Reviews / Focus on
Fainardi, Valentina
Longo, Francesco
Chetta, Alfredo
Esposito, Susanna
Pisi, Giovanna
SARS-CoV-2 Infection in patients with cystic fibrosis. An overwiew
title SARS-CoV-2 Infection in patients with cystic fibrosis. An overwiew
title_full SARS-CoV-2 Infection in patients with cystic fibrosis. An overwiew
title_fullStr SARS-CoV-2 Infection in patients with cystic fibrosis. An overwiew
title_full_unstemmed SARS-CoV-2 Infection in patients with cystic fibrosis. An overwiew
title_short SARS-CoV-2 Infection in patients with cystic fibrosis. An overwiew
title_sort sars-cov-2 infection in patients with cystic fibrosis. an overwiew
topic Reviews / Focus on
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716958/
https://www.ncbi.nlm.nih.gov/pubmed/32921729
http://dx.doi.org/10.23750/abm.v91i3.10391
work_keys_str_mv AT fainardivalentina sarscov2infectioninpatientswithcysticfibrosisanoverwiew
AT longofrancesco sarscov2infectioninpatientswithcysticfibrosisanoverwiew
AT chettaalfredo sarscov2infectioninpatientswithcysticfibrosisanoverwiew
AT espositosusanna sarscov2infectioninpatientswithcysticfibrosisanoverwiew
AT pisigiovanna sarscov2infectioninpatientswithcysticfibrosisanoverwiew

Ejemplares similares